A comprehensive examination and analysis of the effectiveness and safety of finerenone for the treatment of diabetic kidney disease: a systematic review and meta-analysis

ObjectivesThe study will evaluate the effectiveness and safety of finerenone in patients diagnosed with diabetic kidney disease (DKD).MethodsVarious databases including PubMed, Sinomed, Web of Science, Embase, Clinical Trials, and Cochrane Library were systematically reviewed for pertinent studies p...

Full description

Saved in:
Bibliographic Details
Main Authors: Jianyu Chen, Jisu Xue, Jiahui Chen, Tingfei Xie, Xiaolu Sui, Yanzi Zhang, Aisha Zhang, Yunpeng Xu, Jihong Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-12-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2024.1461754/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846114934315810816
author Jianyu Chen
Jianyu Chen
Jisu Xue
Jiahui Chen
Jiahui Chen
Tingfei Xie
Tingfei Xie
Xiaolu Sui
Xiaolu Sui
Yanzi Zhang
Yanzi Zhang
Aisha Zhang
Aisha Zhang
Yunpeng Xu
Yunpeng Xu
Jihong Chen
Jihong Chen
author_facet Jianyu Chen
Jianyu Chen
Jisu Xue
Jiahui Chen
Jiahui Chen
Tingfei Xie
Tingfei Xie
Xiaolu Sui
Xiaolu Sui
Yanzi Zhang
Yanzi Zhang
Aisha Zhang
Aisha Zhang
Yunpeng Xu
Yunpeng Xu
Jihong Chen
Jihong Chen
author_sort Jianyu Chen
collection DOAJ
description ObjectivesThe study will evaluate the effectiveness and safety of finerenone in patients diagnosed with diabetic kidney disease (DKD).MethodsVarious databases including PubMed, Sinomed, Web of Science, Embase, Clinical Trials, and Cochrane Library were systematically reviewed for pertinent studies published from the beginning to February 2024.This meta-analysis utilized RevMan 5.3 and Stata 15.1.ResultsThe analysis of 4 randomized controlled trials involving 13,943 participants found that finerenone treatment significantly decreased the urine albumin-to-creatinine ratio compared to placebo. Additionally, the risk of COVID-19, cardiovascular events, and estimated glomerular filtration rate(eGFR) reduction of at least 40% were all significantly lower in the finerenone treatment group. However, the finerenone group did experience higher baseline increases in serum potassium levels. The meta-analysis revealed that there was no variation in the likelihood of general negative outcomes (RR 1.00, 95% CI 0.98, 1.01, I2 = 0%) and the occurrence of cancers (RR 0.99, 95% CI 0.83, 1.18,I2 = 0%) among the two categories.ConclusionOur study demonstrates that finerenone has the potential to lower the chances of end-stage kidney disease, renal failure and cardiovascular mortality in individuals with diabetic kidney disease. It is important to monitor for hyperkalemia risk. The administration of finelidone among individuals with diabetic kidney disease may potentially mitigate the susceptibility to contracting COVID-19.Systematic review registrationhttps://www.crd.york.ac.uk/prospero/, identifier CRD42024536612.
format Article
id doaj-art-2d11d5d10be84cedabd6c5c6048c7ab5
institution Kabale University
issn 1664-2392
language English
publishDate 2024-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj-art-2d11d5d10be84cedabd6c5c6048c7ab52024-12-20T05:10:15ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922024-12-011510.3389/fendo.2024.14617541461754A comprehensive examination and analysis of the effectiveness and safety of finerenone for the treatment of diabetic kidney disease: a systematic review and meta-analysisJianyu Chen0Jianyu Chen1Jisu Xue2Jiahui Chen3Jiahui Chen4Tingfei Xie5Tingfei Xie6Xiaolu Sui7Xiaolu Sui8Yanzi Zhang9Yanzi Zhang10Aisha Zhang11Aisha Zhang12Yunpeng Xu13Yunpeng Xu14Jihong Chen15Jihong Chen16Department of Nephrology, The Second People’s Hospital of Shenzhen, Shenzhen, ChinaDepartment of Nephrology, Affiliated Bao’an Hospital of Shenzhen, The Second School of Clinical Medicine, Southern Medical University, Shenzhen, ChinaDepartment of Endocrinology,The People’s Hospital of Baoan Shenzhen, Shenzhen, ChinaDepartment of Nephrology, Affiliated Bao’an Hospital of Shenzhen, The Second School of Clinical Medicine, Southern Medical University, Shenzhen, ChinaDepartment of Nephrology, The People’s Hospital of Baoan Shenzhen, Shenzhen, ChinaDepartment of Nephrology, Affiliated Bao’an Hospital of Shenzhen, The Second School of Clinical Medicine, Southern Medical University, Shenzhen, ChinaDepartment of Nephrology, The People’s Hospital of Baoan Shenzhen, Shenzhen, ChinaDepartment of Nephrology, Affiliated Bao’an Hospital of Shenzhen, The Second School of Clinical Medicine, Southern Medical University, Shenzhen, ChinaDepartment of Nephrology, The People’s Hospital of Baoan Shenzhen, Shenzhen, ChinaDepartment of Nephrology, Affiliated Bao’an Hospital of Shenzhen, The Second School of Clinical Medicine, Southern Medical University, Shenzhen, ChinaDepartment of Nephrology, The People’s Hospital of Baoan Shenzhen, Shenzhen, ChinaDepartment of Nephrology, Affiliated Bao’an Hospital of Shenzhen, The Second School of Clinical Medicine, Southern Medical University, Shenzhen, ChinaDepartment of Nephrology, The People’s Hospital of Baoan Shenzhen, Shenzhen, ChinaDepartment of Nephrology, Affiliated Bao’an Hospital of Shenzhen, The Second School of Clinical Medicine, Southern Medical University, Shenzhen, ChinaDepartment of Nephrology, The People’s Hospital of Baoan Shenzhen, Shenzhen, ChinaDepartment of Nephrology, Affiliated Bao’an Hospital of Shenzhen, The Second School of Clinical Medicine, Southern Medical University, Shenzhen, ChinaDepartment of Nephrology, The People’s Hospital of Baoan Shenzhen, Shenzhen, ChinaObjectivesThe study will evaluate the effectiveness and safety of finerenone in patients diagnosed with diabetic kidney disease (DKD).MethodsVarious databases including PubMed, Sinomed, Web of Science, Embase, Clinical Trials, and Cochrane Library were systematically reviewed for pertinent studies published from the beginning to February 2024.This meta-analysis utilized RevMan 5.3 and Stata 15.1.ResultsThe analysis of 4 randomized controlled trials involving 13,943 participants found that finerenone treatment significantly decreased the urine albumin-to-creatinine ratio compared to placebo. Additionally, the risk of COVID-19, cardiovascular events, and estimated glomerular filtration rate(eGFR) reduction of at least 40% were all significantly lower in the finerenone treatment group. However, the finerenone group did experience higher baseline increases in serum potassium levels. The meta-analysis revealed that there was no variation in the likelihood of general negative outcomes (RR 1.00, 95% CI 0.98, 1.01, I2 = 0%) and the occurrence of cancers (RR 0.99, 95% CI 0.83, 1.18,I2 = 0%) among the two categories.ConclusionOur study demonstrates that finerenone has the potential to lower the chances of end-stage kidney disease, renal failure and cardiovascular mortality in individuals with diabetic kidney disease. It is important to monitor for hyperkalemia risk. The administration of finelidone among individuals with diabetic kidney disease may potentially mitigate the susceptibility to contracting COVID-19.Systematic review registrationhttps://www.crd.york.ac.uk/prospero/, identifier CRD42024536612.https://www.frontiersin.org/articles/10.3389/fendo.2024.1461754/fulldiabetic kidney diseaserenal functionCOVID-19malignancyfinerenonemeta-analysis
spellingShingle Jianyu Chen
Jianyu Chen
Jisu Xue
Jiahui Chen
Jiahui Chen
Tingfei Xie
Tingfei Xie
Xiaolu Sui
Xiaolu Sui
Yanzi Zhang
Yanzi Zhang
Aisha Zhang
Aisha Zhang
Yunpeng Xu
Yunpeng Xu
Jihong Chen
Jihong Chen
A comprehensive examination and analysis of the effectiveness and safety of finerenone for the treatment of diabetic kidney disease: a systematic review and meta-analysis
Frontiers in Endocrinology
diabetic kidney disease
renal function
COVID-19
malignancy
finerenone
meta-analysis
title A comprehensive examination and analysis of the effectiveness and safety of finerenone for the treatment of diabetic kidney disease: a systematic review and meta-analysis
title_full A comprehensive examination and analysis of the effectiveness and safety of finerenone for the treatment of diabetic kidney disease: a systematic review and meta-analysis
title_fullStr A comprehensive examination and analysis of the effectiveness and safety of finerenone for the treatment of diabetic kidney disease: a systematic review and meta-analysis
title_full_unstemmed A comprehensive examination and analysis of the effectiveness and safety of finerenone for the treatment of diabetic kidney disease: a systematic review and meta-analysis
title_short A comprehensive examination and analysis of the effectiveness and safety of finerenone for the treatment of diabetic kidney disease: a systematic review and meta-analysis
title_sort comprehensive examination and analysis of the effectiveness and safety of finerenone for the treatment of diabetic kidney disease a systematic review and meta analysis
topic diabetic kidney disease
renal function
COVID-19
malignancy
finerenone
meta-analysis
url https://www.frontiersin.org/articles/10.3389/fendo.2024.1461754/full
work_keys_str_mv AT jianyuchen acomprehensiveexaminationandanalysisoftheeffectivenessandsafetyoffinerenoneforthetreatmentofdiabetickidneydiseaseasystematicreviewandmetaanalysis
AT jianyuchen acomprehensiveexaminationandanalysisoftheeffectivenessandsafetyoffinerenoneforthetreatmentofdiabetickidneydiseaseasystematicreviewandmetaanalysis
AT jisuxue acomprehensiveexaminationandanalysisoftheeffectivenessandsafetyoffinerenoneforthetreatmentofdiabetickidneydiseaseasystematicreviewandmetaanalysis
AT jiahuichen acomprehensiveexaminationandanalysisoftheeffectivenessandsafetyoffinerenoneforthetreatmentofdiabetickidneydiseaseasystematicreviewandmetaanalysis
AT jiahuichen acomprehensiveexaminationandanalysisoftheeffectivenessandsafetyoffinerenoneforthetreatmentofdiabetickidneydiseaseasystematicreviewandmetaanalysis
AT tingfeixie acomprehensiveexaminationandanalysisoftheeffectivenessandsafetyoffinerenoneforthetreatmentofdiabetickidneydiseaseasystematicreviewandmetaanalysis
AT tingfeixie acomprehensiveexaminationandanalysisoftheeffectivenessandsafetyoffinerenoneforthetreatmentofdiabetickidneydiseaseasystematicreviewandmetaanalysis
AT xiaolusui acomprehensiveexaminationandanalysisoftheeffectivenessandsafetyoffinerenoneforthetreatmentofdiabetickidneydiseaseasystematicreviewandmetaanalysis
AT xiaolusui acomprehensiveexaminationandanalysisoftheeffectivenessandsafetyoffinerenoneforthetreatmentofdiabetickidneydiseaseasystematicreviewandmetaanalysis
AT yanzizhang acomprehensiveexaminationandanalysisoftheeffectivenessandsafetyoffinerenoneforthetreatmentofdiabetickidneydiseaseasystematicreviewandmetaanalysis
AT yanzizhang acomprehensiveexaminationandanalysisoftheeffectivenessandsafetyoffinerenoneforthetreatmentofdiabetickidneydiseaseasystematicreviewandmetaanalysis
AT aishazhang acomprehensiveexaminationandanalysisoftheeffectivenessandsafetyoffinerenoneforthetreatmentofdiabetickidneydiseaseasystematicreviewandmetaanalysis
AT aishazhang acomprehensiveexaminationandanalysisoftheeffectivenessandsafetyoffinerenoneforthetreatmentofdiabetickidneydiseaseasystematicreviewandmetaanalysis
AT yunpengxu acomprehensiveexaminationandanalysisoftheeffectivenessandsafetyoffinerenoneforthetreatmentofdiabetickidneydiseaseasystematicreviewandmetaanalysis
AT yunpengxu acomprehensiveexaminationandanalysisoftheeffectivenessandsafetyoffinerenoneforthetreatmentofdiabetickidneydiseaseasystematicreviewandmetaanalysis
AT jihongchen acomprehensiveexaminationandanalysisoftheeffectivenessandsafetyoffinerenoneforthetreatmentofdiabetickidneydiseaseasystematicreviewandmetaanalysis
AT jihongchen acomprehensiveexaminationandanalysisoftheeffectivenessandsafetyoffinerenoneforthetreatmentofdiabetickidneydiseaseasystematicreviewandmetaanalysis
AT jianyuchen comprehensiveexaminationandanalysisoftheeffectivenessandsafetyoffinerenoneforthetreatmentofdiabetickidneydiseaseasystematicreviewandmetaanalysis
AT jianyuchen comprehensiveexaminationandanalysisoftheeffectivenessandsafetyoffinerenoneforthetreatmentofdiabetickidneydiseaseasystematicreviewandmetaanalysis
AT jisuxue comprehensiveexaminationandanalysisoftheeffectivenessandsafetyoffinerenoneforthetreatmentofdiabetickidneydiseaseasystematicreviewandmetaanalysis
AT jiahuichen comprehensiveexaminationandanalysisoftheeffectivenessandsafetyoffinerenoneforthetreatmentofdiabetickidneydiseaseasystematicreviewandmetaanalysis
AT jiahuichen comprehensiveexaminationandanalysisoftheeffectivenessandsafetyoffinerenoneforthetreatmentofdiabetickidneydiseaseasystematicreviewandmetaanalysis
AT tingfeixie comprehensiveexaminationandanalysisoftheeffectivenessandsafetyoffinerenoneforthetreatmentofdiabetickidneydiseaseasystematicreviewandmetaanalysis
AT tingfeixie comprehensiveexaminationandanalysisoftheeffectivenessandsafetyoffinerenoneforthetreatmentofdiabetickidneydiseaseasystematicreviewandmetaanalysis
AT xiaolusui comprehensiveexaminationandanalysisoftheeffectivenessandsafetyoffinerenoneforthetreatmentofdiabetickidneydiseaseasystematicreviewandmetaanalysis
AT xiaolusui comprehensiveexaminationandanalysisoftheeffectivenessandsafetyoffinerenoneforthetreatmentofdiabetickidneydiseaseasystematicreviewandmetaanalysis
AT yanzizhang comprehensiveexaminationandanalysisoftheeffectivenessandsafetyoffinerenoneforthetreatmentofdiabetickidneydiseaseasystematicreviewandmetaanalysis
AT yanzizhang comprehensiveexaminationandanalysisoftheeffectivenessandsafetyoffinerenoneforthetreatmentofdiabetickidneydiseaseasystematicreviewandmetaanalysis
AT aishazhang comprehensiveexaminationandanalysisoftheeffectivenessandsafetyoffinerenoneforthetreatmentofdiabetickidneydiseaseasystematicreviewandmetaanalysis
AT aishazhang comprehensiveexaminationandanalysisoftheeffectivenessandsafetyoffinerenoneforthetreatmentofdiabetickidneydiseaseasystematicreviewandmetaanalysis
AT yunpengxu comprehensiveexaminationandanalysisoftheeffectivenessandsafetyoffinerenoneforthetreatmentofdiabetickidneydiseaseasystematicreviewandmetaanalysis
AT yunpengxu comprehensiveexaminationandanalysisoftheeffectivenessandsafetyoffinerenoneforthetreatmentofdiabetickidneydiseaseasystematicreviewandmetaanalysis
AT jihongchen comprehensiveexaminationandanalysisoftheeffectivenessandsafetyoffinerenoneforthetreatmentofdiabetickidneydiseaseasystematicreviewandmetaanalysis
AT jihongchen comprehensiveexaminationandanalysisoftheeffectivenessandsafetyoffinerenoneforthetreatmentofdiabetickidneydiseaseasystematicreviewandmetaanalysis